Growth Metrics

Eli Lilly (LLY) Cash from Investing Activities Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -24.99%
Dec 31, 2025 -32.97%
Sep 30, 2025 -56.92%
Jun 30, 2025 -54.20%
Mar 31, 2025 -25.88%
Dec 31, 2024 -115.43%
Sep 30, 2024 -56.70%
Jun 30, 2024 -107.04%
Mar 31, 2024 31.27%
Dec 31, 2023 -34.72%
Sep 30, 2023 -50.57%
Jun 30, 2023 -16.51%
Mar 31, 2023 -32.24%
Dec 31, 2022 -20.79%
Sep 30, 2022 11.48%
Jun 30, 2022 18.14%
Mar 31, 2022 6.21%
Dec 31, 2021 16.29%
Sep 30, 2021 4.95%
Jun 30, 2021 13.89%
Mar 31, 2021 -54.58%
Dec 31, 2020 -36.03%
Sep 30, 2020 11.27%
Jun 30, 2020 -25.82%
Mar 31, 2020 -53.77%
Dec 31, 2019 54.74%
Sep 30, 2019 23.80%
Jun 30, 2019 16.33%
Mar 31, 2019 -85.17%
Dec 31, 2018 11.77%
Sep 30, 2018 15.86%
Jun 30, 2018 35.12%
Mar 31, 2018 -16.28%
Dec 31, 2017 24.53%
Sep 30, 2017 -67.66%
Jun 30, 2017 -42.31%
Mar 31, 2017 -16.99%
Dec 31, 2016 8.89%
Sep 30, 2016 4.65%
Jun 30, 2016 11.67%
Mar 31, 2016 -29.00%
Dec 31, 2015 16.67%
Sep 30, 2015 6.28%
Jun 30, 2015 17.52%
Mar 31, 2015 38.29%
Dec 31, 2014 -53.67%
Sep 30, 2014 -92.40%
Jun 30, 2014 -45.82%
Mar 31, 2014 11.31%